The Patent Finder

Armetheon, Inc.

Also on record
Records under this name other than patents Armetheon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Armetheon, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,498,449Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,549,912Methods for Treating Atrial Fibrillation
Formerly held
In force (reinstated)
 · Medium confidence
In force (reinstated)Medium confidence
US 7,326,787Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Formerly held
Term ended
Term ended Aug 31, 2026 · High confidence
Term endedTerm ended Aug 31, 2026High confidence
US 7,629,466Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Formerly held
Term ended
Term ended Aug 31, 2026 · Medium confidence
Term endedTerm ended Aug 31, 2026Medium confidence
US 7,176,218Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Formerly held
Term ended
Term ended Aug 21, 2025 · High confidence
Term endedTerm ended Aug 21, 2025High confidence
US 8,138,204Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Formerly held
Term ended
Term ended Aug 21, 2025 · High confidence
Term endedTerm ended Aug 21, 2025High confidence
US 7,282,509Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Formerly held
Term ended
Term ended May 27, 2025 · High confidence
Term endedTerm ended May 27, 2025High confidence
US 7,105,568Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Formerly held
Term ended
Term ended Apr 8, 2025 · High confidence
Term endedTerm ended Apr 8, 2025High confidence
US 8,524,736Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
Formerly held
Term ended
Ended no later than Jan 7, 2025 · USPTO record
Term endedEnded no later than Jan 7, 2025USPTO record
US 6,869,972Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Formerly held
Term ended
Term ended Dec 10, 2022 · High confidence
Term endedTerm ended Dec 10, 2022High confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited